Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.040
Sell
RSI(14)
25.136
Sell
STOCH(KDJ)(9,3,3)
14.929
Oversold
ATR(14)
0.103
Low Volatility
CCI(14)
-107.674
Sell
Williams %R
88.479
Oversold
TRIX(12,20)
-1.616
Sell
StochRSI(14)
0.000
Oversold
Search
BioNexus Gene Lab Corp
BGLCAdd to Watchlist
1.280USD
-0.040-3.03%
Close 07-31 16:00（ET）Quotes delayed by 15 min
3.09MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-3.03%
5 Days
-15.23%
1 Month
-34.36%
6 Months
-50.71%
Year to Date
-67.59%
1 Year
-81.53%
Key Figures
--Open
1.370High
10.01KVolume
LossP/E TTM
--P/E Dynamic
--Dividend TTM
0.41%Turnover Ratio
1.320Prev. Close
1.270Low
10.76KTurnover
LossP/E Static
0.38P/B
0.00%Div Yield TTM
-31.37%ROA
15.60052wk High
0.43Volume Ratio
-1.60MNet Profit
2.42MShares
-1.4855EPS TTM
2.20Beta
-36.62%ROE
1.92052wk Low
7.58%Amplitude
-3.46%Gross Margin
3.09MMarket Cap
-7.79Reward/Risk
4.49%Risk Rate
TradingKey Stock Score of BioNexus Gene Lab Corp
Currency: USD Updated: 2026-07-31Key Insights
BioNexus Gene Lab Corp's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 190 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
BioNexus Gene Lab Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
BioNexus Gene Lab Corp Highlights
StrengthsRisks
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Growing
The company is in a growing phase, with the latest annual income totaling USD 7.42M.
Overvalued
The company’s latest PE is -0.89, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 50.43K shares, increasing 16.55% quarter-over-quarter.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
BioNexus Gene Lab Corp News
More news coming soon, stay tuned...
Indicators
Moving Average
Indicators
Value
Direction
MA5
1.344
Sell
MA10
1.461
Sell
MA20
1.623
Sell
MA50
1.976
Sell
MA100
2.099
Sell
MA200
2.971
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
BioNexus Gene Lab Corp Info
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Ticker SymbolBGLC
CompanyBioNexus Gene Lab Corp
CEOTan (Lee Su-Leng)
Websitehttps://www.bionexusgenelab.com/
Shareholders
Related Instruments
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of BioNexus Gene Lab Corp (BGLC)?
The current price of BioNexus Gene Lab Corp (BGLC) is 1.28.
What is the symbol of BioNexus Gene Lab Corp?
The ticker symbol of BioNexus Gene Lab Corp is BGLC.
What is the 52-week high of BioNexus Gene Lab Corp?
The 52-week high of BioNexus Gene Lab Corp is 15.60.
What is the 52-week low of BioNexus Gene Lab Corp?
The 52-week low of BioNexus Gene Lab Corp is 1.92.
What is the market capitalization of BioNexus Gene Lab Corp?
The market capitalization of BioNexus Gene Lab Corp is 3.09M.
What is the Earnings Per Share (EPS TTM) of BioNexus Gene Lab Corp (BGLC)?
The Earnings Per Share (EPS TTM) of BioNexus Gene Lab Corp (BGLC) is -1.61.